Cite
Effectiveness of originator (Neupogen) and biosimilar (Zarzio) filgrastim in autologous peripheral blood stem cell mobilization in adults with acute myeloid leukemia: a single-center retrospective study
MLA
Vincenzo Nasillo, et al. “Effectiveness of Originator (Neupogen) and Biosimilar (Zarzio) Filgrastim in Autologous Peripheral Blood Stem Cell Mobilization in Adults with Acute Myeloid Leukemia: A Single-Center Retrospective Study.” Leukemialymphoma, vol. 59, no. 1, June 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f114180d6da8446a5985476a51901f2b&authtype=sso&custid=ns315887.
APA
Vincenzo Nasillo, Elisabetta Lugli, Valeria Pioli, Laura Arletti, Paola Bresciani, Monica Maccaferri, Valeria Coluccio, Elisabetta Colaci, Mario Luppi, Andrea Messerotti, G. Ceccherelli, Maria Teresa Mariano, Angela Cuoghi, Ambra Paolini, Ivana Lagreca, Franco Narni, Chiara Quadrelli, Valeria Fantuzzi, Daniele Campioli, … Monica Morselli. (2017). Effectiveness of originator (Neupogen) and biosimilar (Zarzio) filgrastim in autologous peripheral blood stem cell mobilization in adults with acute myeloid leukemia: a single-center retrospective study. Leukemialymphoma, 59(1).
Chicago
Vincenzo Nasillo, Elisabetta Lugli, Valeria Pioli, Laura Arletti, Paola Bresciani, Monica Maccaferri, Valeria Coluccio, et al. 2017. “Effectiveness of Originator (Neupogen) and Biosimilar (Zarzio) Filgrastim in Autologous Peripheral Blood Stem Cell Mobilization in Adults with Acute Myeloid Leukemia: A Single-Center Retrospective Study.” Leukemialymphoma 59 (1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f114180d6da8446a5985476a51901f2b&authtype=sso&custid=ns315887.